Plasma cfDNA whole-exome sequencing to characterize tumor mutation landscape and track cancer evolution 

In the following Condalab Talks, Dr. Rodrigo Toledo will explain how they apply the ThruPLEX Plasma- seq technology to sequence cfDNA of sequential plasma samples of patients collected before, during, and at progression to different cancer therapies.

Topics discussed:

- Usage of ThruPLEX Plasma-seq to:

1) Identify new mechanisms of resistance to cancer therapies.

2) Track cancer clonal evolution.

3) Evaluate the role of cfDNA on the survival of patients treated with cancer immunotherapy.

¡No te pierdas esta oportunidad!

Rellena este formulario y accede al webinar.